News of Note— A CAR-T for prostate cancer; targeting a faulty dementia gene; prompting cell suicide to treat leukemia – FierceBiotech
FierceBiotech |
News of Note— A CAR–T for prostate cancer; targeting a faulty dementia gene; prompting cell suicide to treat leukemia
FierceBiotech San Diego-based Poseida Therapeutics is developing a chimeric antigen receptor T cell (CAR-T) therapy for prostate tumors that's showing early promise in a particularly aggressive strain of the disease. Researchers at the company implanted human cell … |
